Rockwell Medical Inc Asset Resilience Ratio
Rockwell Medical Inc asset resilience ratio. Rockwell Medical Inc (RMTI) has an Asset Resilience Ratio of 25.26% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Rockwell Medical Inc to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Rockwell Medical Inc (2000–2025)
Asset resilience ratio of Rockwell Medical Inc from 2000 to 2025. This chart shows how Rockwell Medical Inc's Asset Resilience Ratio has changed over time. Read total liabilities of Rockwell Medical Inc for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Rockwell Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see RMTI total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $14.28 Million | 25.26% |
| Total Liquid Assets | $14.28 Million | 25.26% |
Asset Resilience Insights
- Very High Liquidity: Rockwell Medical Inc maintains exceptional liquid asset reserves at 25.26% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Rockwell Medical Inc Industry Peers by Asset Resilience Ratio
Compare Rockwell Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Rockwell Medical Inc Asset Resilience Ratio by Year (2000–2025)
Rockwell Medical Inc asset resilience ratio by year from 2000 to 2025. The table below shows the annual Asset Resilience Ratio data for Rockwell Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 25.00% | $14.29 Million | $57.15 Million | +14.97pp |
| 2024-12-31 | 10.03% | $5.94 Million | $59.21 Million | +6.29pp |
| 2023-12-31 | 3.74% | $1.95 Million | $52.17 Million | -20.68pp |
| 2022-12-31 | 24.42% | $11.39 Million | $46.63 Million | +5.57pp |
| 2021-12-31 | 18.85% | $9.16 Million | $48.57 Million | +6.00pp |
| 2020-12-31 | 12.86% | $10.00 Million | $77.75 Million | -19.30pp |
| 2019-12-31 | 32.15% | $14.25 Million | $44.32 Million | +11.57pp |
| 2018-12-31 | 20.58% | $10.82 Million | $52.56 Million | -21.35pp |
| 2017-12-31 | 41.93% | $24.65 Million | $58.78 Million | -7.08pp |
| 2016-12-31 | 49.02% | $40.76 Million | $83.15 Million | +4.06pp |
| 2015-12-31 | 44.96% | $39.48 Million | $87.82 Million | +24.62pp |
| 2014-12-31 | 20.33% | $19.93 Million | $98.00 Million | -12.76pp |
| 2013-12-31 | 33.10% | $12.03 Million | $36.36 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $17.03 Million | -- |
| 2011-12-31 | 36.98% | $11.81 Million | $31.94 Million | +4.68pp |
| 2010-12-31 | 32.29% | $11.94 Million | $36.97 Million | +32.18pp |
| 2004-12-31 | 0.12% | $9.00K | $7.70 Million | -0.01pp |
| 2003-12-31 | 0.13% | $9.00K | $7.04 Million | -0.09pp |
| 2002-12-31 | 0.22% | $14.00K | $6.45 Million | -4.62pp |
| 2001-12-31 | 4.84% | $293.00K | $6.06 Million | +1.13pp |
| 2000-12-31 | 3.70% | $150.00K | $4.05 Million | -- |
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more